Cases 11 - 20 of 126
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al
as 1:2022cv01462
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00965
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00513
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Journey Medical Corporation et al v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00288
Plaintiff:
Journey Medical Corporation and Rose U, LLC
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00221
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00083
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00092
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Development, Inc. et al
as 1:2021cv01353
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
